TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TEST TYPE (USD BILLION)
6.1. Cell-Free DNA Testing
6.2. Biochemical Testing
6.3. Combined Screening
7. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION (USD BILLION)
7.1. Fetal Gender Determination
7.2. Chromosomal Abnormalities Screening
7.3. Rhesus Disease Screening
8. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNOLOGY (USD BILLION)
8.1. Next Generation Sequencing
8.2. Microarray Analysis
8.3. Polymerase Chain Reaction
9. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER (USD BILLION)
9.1. Hospitals
9.2. Diagnostic Laboratories
9.3. Direct-to-Consumer Companies
10. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Non-Invasive Prenatal Testing (NIPT) Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Non-Invasive Prenatal Testing (NIPT) Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Lifecodexx
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Qiagen
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Eurofins Scientific
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Genomatix
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Natera
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. BGI Genomics
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Illumina
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Haplogen
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. MedGenome
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Myriad Genetics
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Fulgent Genetics
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Roche
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Quest Diagnostics
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Laboratory Corporation of America
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 9. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 10. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 11. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 29. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 30. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 31. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 59. APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 60. APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 61. APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 129. MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 130. MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 131. MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS
FIGURE 3. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 4. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 5. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 6. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 7. US NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 9. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 10. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 11. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 12. CANADA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS
FIGURE 14. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 15. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 16. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 17. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 18. GERMANY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 20. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 21. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 22. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 23. UK NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 25. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 26. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 27. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 28. FRANCE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 30. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 31. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 32. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 33. RUSSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 35. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 36. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 37. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 38. ITALY NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 40. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 41. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 42. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 43. SPAIN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 45. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 46. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 47. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 48. REST OF EUROPE NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS
FIGURE 50. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 51. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 52. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 53. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 54. CHINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 56. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 57. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 58. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 59. INDIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 61. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 62. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 63. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 64. JAPAN NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 66. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 67. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 68. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 69. SOUTH KOREA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 71. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 72. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 73. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 74. MALAYSIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 76. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 77. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 78. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 79. THAILAND NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 81. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 82. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 83. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 84. INDONESIA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 86. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 87. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 88. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 89. REST OF APAC NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS
FIGURE 91. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 92. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 93. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 94. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 95. BRAZIL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 97. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 98. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 99. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 100. MEXICO NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 102. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 103. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 104. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 105. ARGENTINA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 107. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 108. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 109. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 110. REST OF SOUTH AMERICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 113. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 114. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 115. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 116. GCC COUNTRIES NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 118. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 119. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 120. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 121. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TEST TYPE
FIGURE 123. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY APPLICATION
FIGURE 124. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY TECHNOLOGY
FIGURE 125. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY END USER
FIGURE 126. REST OF MEA NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF NON-INVASIVE PRENATAL TESTING (NIPT) MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT) MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: NON-INVASIVE PRENATAL TESTING (NIPT) MARKET
FIGURE 133. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TEST TYPE, 2024 (% SHARE)
FIGURE 134. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TEST TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 136. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 137. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNOLOGY, 2024 (% SHARE)
FIGURE 138. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY TECHNOLOGY, 2019 TO 2032 (USD Billions)
FIGURE 139. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2024 (% SHARE)
FIGURE 140. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 141. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
